Fungal microbiota dysbiosis in IBD

Objective The bacterial intestinal microbiota plays major roles in human physiology and IBDs. Although some data suggest a role of the fungal microbiota in IBD pathogenesis, the available data are scarce. The aim of our study was to characterise the faecal fungal microbiota in patients with IBD. Design Bacterial and fungal composition of the faecal microbiota of 235 patients with IBD and 38 healthy subjects (HS) was determined using 16S and ITS2 sequencing, respectively. The obtained sequences were analysed using the Qiime pipeline to assess composition and diversity. Bacterial and fungal taxa associated with clinical parameters were identified using multivariate association with linear models. Correlation between bacterial and fungal microbiota was investigated using Spearman's test and distance correlation. Results We observed that fungal microbiota is skewed in IBD, with an increased Basidiomycota/Ascomycota ratio, a decreased proportion of Saccharomyces cerevisiae and an increased proportion of Candida albicans compared with HS. We also identified disease-specific alterations in diversity, indicating that a Crohn's disease-specific gut environment may favour fungi at the expense of bacteria. The concomitant analysis of bacterial and fungal microbiota showed a dense and homogenous correlation network in HS but a dramatically unbalanced network in IBD, suggesting the existence of disease-specific inter-kingdom alterations. Conclusions Besides bacterial dysbiosis, our study identifies a distinct fungal microbiota dysbiosis in IBD characterised by alterations in biodiversity and composition. Moreover, we unravel here disease-specific inter-kingdom network alterations in IBD, suggesting that, beyond bacteria, fungi might also play a role in IBD pathogenesis.

[1]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[2]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[3]  M. Ghannoum,et al.  Mycobiota in gastrointestinal diseases , 2015, Nature Reviews Gastroenterology &Hepatology.

[4]  Hongzhe Li,et al.  Archaea and Fungi of the Human Gut Microbiome: Correlations with Diet and Bacterial Residents , 2013, PloS one.

[5]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[6]  Philip Rosenstiel,et al.  NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. , 2013, The Journal of clinical investigation.

[7]  Jenny Sauk,et al.  Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease , 2015, Cell.

[8]  P. García-Pavía,et al.  Gene network and familial analyses uncover a gene network involving Tbx5/Osr1/Pcsk6 interaction in the second heart field for atrial septation. , 2016, Human molecular genetics.

[9]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[10]  K. Faber,et al.  The ATG16L1–T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients , 2014, Gut.

[11]  P. Rutgeerts,et al.  Environmental Factors in Familial Crohn's Disease in Belgium , 2005, Inflammatory bowel diseases.

[12]  G. Liguori,et al.  Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[13]  V. Tremaroli,et al.  Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88 , 2011, Gut.

[14]  D. Poulain,et al.  Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. , 2007, Medical mycology.

[15]  R. Tibshirani,et al.  Comment on "Detecting Novel Associations In Large Data Sets" by Reshef Et Al, Science Dec 16, 2011 , 2014, 1401.7645.

[16]  F. Bushman,et al.  Fungi of the Murine Gut: Episodic Variation and Proliferation during Antibiotic Treatment , 2013, PloS one.

[17]  Thierry Jouault,et al.  Candida albicans Colonization and ASCA in Familial Crohn's Disease , 2009, The American Journal of Gastroenterology.

[18]  P. Rosenstiel,et al.  NOD 2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer , 2013 .

[19]  Anders F. Andersson,et al.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.

[20]  G. Nilsson,et al.  TLR2/MyD88-Dependent and -Independent Activation of Mast Cell IgE Responses by the Skin Commensal Yeast Malassezia sympodialis1 , 2009, The Journal of Immunology.

[21]  P. Parsons-Wingerter,et al.  Probiotic Yeast Inhibits VEGFR Signaling and Angiogenesis in Intestinal Inflammation , 2013, PloS one.

[22]  L. Stateva,et al.  Genotypic and Physiological Characterization of Saccharomyces boulardii, the Probiotic Strain of Saccharomyces cerevisiae , 2007, Applied and Environmental Microbiology.

[23]  L. Mcfarland.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. , 2010, World journal of gastroenterology.

[24]  R. Xavier,et al.  Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. , 2013, Gastroenterology.

[25]  Malka Gorfine,et al.  Comment on “ Detecting Novel Associations in Large Data Sets ” , 2012 .

[26]  M. Dubinsky,et al.  Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis , 2012, Science.

[27]  S. Mordon,et al.  Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. , 2008, The Journal of infectious diseases.

[28]  F. Bushman,et al.  Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease , 2015, Inflammatory Bowel Diseases.

[29]  J. Wehkamp,et al.  Defensins and other antimicrobial peptides in inflammatory bowel disease , 2007, Current opinion in gastroenterology.

[30]  H. Sokol,et al.  Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases , 2012, Gut.

[31]  M. Selsted,et al.  Mammalian defensins in the antimicrobial immune response , 2005, Nature Immunology.

[32]  Maria L. Rizzo,et al.  Brownian distance covariance , 2009, 1010.0297.

[33]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[34]  Eric P. Nawrocki,et al.  An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea , 2011, The ISME Journal.

[35]  A. Sivignon,et al.  Saccharomyces cerevisiae CNCM I-3856 Prevents Colitis Induced by AIEC Bacteria in the Transgenic Mouse Model Mimicking Crohn's Disease , 2015, Inflammatory bowel diseases.

[36]  Trees Jansen,et al.  Human dectin-1 deficiency and mucocutaneous fungal infections. , 2009, The New England journal of medicine.

[37]  K. Hemminki,et al.  Dectin-1 and DC-SIGN Polymorphisms Associated with Invasive Pulmonary Aspergillosis Infection , 2012, PloS one.

[38]  Y. Gong,et al.  Evidence for Genetic Association of CARD9 and SNAPC4 with Ankylosing Spondylitis in a Chinese Han Population , 2014, The Journal of Rheumatology.

[39]  J. Heitman,et al.  Malassezia Fungi Are Specialized to Live on Skin and Associated with Dandruff, Eczema, and Other Skin Diseases , 2012, PLoS pathogens.

[40]  L. Dubuquoy,et al.  Modulation of Intestinal Inflammation by Yeasts and Cell Wall Extracts: Strain Dependence and Unexpected Anti-Inflammatory Role of Glucan Fractions , 2012, PloS one.

[41]  Dan Knights,et al.  Complex host genetics influence the microbiome in inflammatory bowel disease , 2014, Genome Medicine.

[42]  K. Hemminki,et al.  Gender-Specific Effects of Genetic Variants within Th1 and Th17 Cell-Mediated Immune Response Genes on the Risk of Developing Rheumatoid Arthritis , 2013, PloS one.

[43]  Y. Cohen,et al.  Analysis of soil bacteria susceptibility to manufactured nanoparticles via data visualization , 2015, Beilstein journal of nanotechnology.

[44]  Michael Weiss,et al.  Towards a unified paradigm for sequence‐based identification of fungi , 2013, Molecular ecology.

[45]  M. Zwolinska-Wcislo,et al.  Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[46]  J. Doré,et al.  Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.

[47]  P. Gillberg,et al.  Bile acids: short and long term effects in the intestine , 2010, Scandinavian journal of gastroenterology.

[48]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[49]  H. Ljunggren,et al.  Natural killer and dendritic cell contact in lesional atopic dermatitis skin--Malassezia-influenced cell interaction. , 2002, The Journal of investigative dermatology.

[50]  S. Takashiba,et al.  Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. , 2003, FEMS immunology and medical microbiology.